This inventor holds 6 USPTO granted patents and 9 published patent applications. Top assignees: Flagship Pioneering Innovations V, Inc., Sail Biomedicines. Active years: 2021-2024.
Company Filing History:
Years Active: 2021-2024
Title: Spencer Cory Peck: Innovator in Pharmaceutical Research
Introduction
Spencer Cory Peck is a notable inventor based in Watertown, MA (US), recognized for his contributions to pharmaceutical research. With a total of six patents to his name, Peck has made significant strides in the field of medical science, particularly in the treatment of neurological and autoimmune disorders.
Latest Patents
Among his latest patents, Peck has developed decarboxylase inhibitors for treating Parkinson's disease. These inhibitors target pathogenic bacterial metabolite production and include pharmaceutical compositions that utilize these inhibitors or their conjugates. Additionally, he has disclosed acylated active agents and methods for their use in treating autoimmune disorders, which involve modulating autoimmunity markers.
Career Highlights
Throughout his career, Spencer Cory Peck has worked with innovative companies such as Flagship Pioneering Innovations and Sail Biomedicines. His work in these organizations has allowed him to push the boundaries of pharmaceutical research and contribute to the development of new treatment methodologies.
Collaborations
Peck has collaborated with esteemed colleagues, including Steven John Taylor and Bernard Lanter. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries in the medical field.
Conclusion
Spencer Cory Peck's innovative work and dedication to pharmaceutical research have positioned him as a key figure in the development of treatments for complex medical conditions. His contributions continue to